tiprankstipranks
Trending News
More News >

Cellebrite establishes Cellebrite Federal Solutions via CyTech acquisition

Cellebrite officially established Cellebrite Federal Solutions, further elevating the Company’s ability to serve the unique needs of the U.S. federal government through its AI-driven Case-to-Closure platform for accelerating justice. This newly established operation builds on the Company’s long and rich history of serving U.S. justice, defense, intelligence and other federal civilian agencies with its world-renowned Case-to-Closure platform, assisting in critical initiatives targeting the safety and protection of all American citizens. A key element of this announcement is the acquisition of Cyber Technology Services. CyTech, which was founded in 2002, brings extensive domain expertise in cybersecurity, digital forensics and incident response services. CyTech’s employees will be part of Cellebrite Federal Solutions, further broadening and complementing Cellebrite’s capabilities and supporting the Company’s ongoing expansion within this customer segment/ The actions announced support the Company’s strategy to substantially broaden its business with U.S. federal customers over the longer term. Terms of the transaction were not disclosed. The new unit will be led by Erik Sachwitz. Erik has led Cellebrite’s U.S. federal business since 2020. In 2023, U.S. federal customers generated approximately 19% of Cellebrite’s annual recurring revenue in the public sector, up 21% from the prior year. Further, Cellebrite Federal Solutions is building a world-class board of independent directors. The four independent directors are:Lt. Gen. ret. Ken Tovo: former Commander of the Green Berets and U.S. Special Forces; Dr. Barry West: former CIO and CISO U.S. Department of Commerce and Department of Homeland Security; Mark Ferrer: former COO of SAP; Barbara Grewe: Sr. Director FBI 9/11 Review Commission.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue